Visual Outcomes of an Enhanced Monofocal Intraocular Lens Targeted for Monovision in Highly Myopic Eyes: a Randomized Controlled Trial
- Sponsor
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Study ID
- NCT07168109
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cataract
- High Myopia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Enhanced monofocal intraocular lens implantation (monovision strategy) — PROCEDUREParticipants will undergo phacoemulsification with the implantation of an enhanced monofocal intraocular lens, targeting -0.5 D in the dominant eye and -2.0 D in the non-dominant eye. The first operated eye will be selected based on the worse corrected distance visual acuity; if both eyes are similar, the eye subjectively perceived by the patient as having worse vision will be chosen. The second eye surgery will be performed within 2 weeks after the first eye surgery. Ocular dominance will be determined preoperatively using the "finger method" . Intraocular lens power will be calculated using multiple formulas \[Emmetropia Verifying Optical (EVO) version 2.0, Kane, LISA\].
- Enhanced monofocal intraocular lens implantation (bilateral myopia strategy) — PROCEDUREParticipants will undergo phacoemulsification with the implantation of an enhanced monofocal intraocular lens, targeting -2.0 D in both eyes. The first operated eye will be selected based on the worse corrected distance visual acuity; if both eyes are similar, the eye subjectively perceived by the patient as having worse vision will be chosen. The second eye surgery will be performed within 2 weeks after the first eye surgery. Ocular dominance will be determined preoperatively using the "finger method". Intraocular lens power will be calculated using multiple formulas \[Emmetropia Verifying Optical (EVO) version 2.0, Kane, LISA\].
Study Details
The goal of this clinical trial is to evaluate whether an enhanced monofocal intraocular lens targeted for monovision can improve visual outcomes in patients with cataract and high myopia (axial length ≥ 26 mm). The main questions it aims to answer are: For people with cataract and high myopia, does an enhanced monofocal intraocular lens targeted for monovision provide greater binocular uncorrected distance visual acuity compared with targeting myopia in both eyes? Does an enhanced monofocal intraocular lens targeted for monovision provide comparable binocular uncorrected intermediate and near visual acuity, contrast sensitivity, reading ability, spectacle independence, stereopsis, and photic phenomena compared with targeting myopia in both eyes? Researchers will compare an enhanced monofocal intraocular lens targeted for monovision with one targeted for myopia in both eyes to determine whether the monovision strategy is more effective. Participants will: Undergo phacoemulsification with enhanced monofocal intraocular lens implantation. Attend follow-up visits at 1, 3, 6, and 12 months after cataract surgery.
Key Dates
- First listed
- Sep 11, 2025
- Start date
- Oct 1, 2025
- Status verified
- Aug 2025
- Primary completion
- Apr 1, 2026
- Completion
- Jul 1, 2027
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Monovision groupBoth eyes will be implanted with enhanced monofocal intraocular lenses, with the dominant eye targeted for -0.5 diopters (D) and the nondominant eye for -2.0 D.
- Active Comparator: Bilateral myopia groupBoth eyes will be implanted with enhanced monofocal intraocular lenses, with each eye targeted for -2.0 D.
Primary Outcome Measure
Binocular uncorrected distance visual acuity at 4 m [ Time Frame: 3 months (±2 weeks) following the second eye surgery ]
Central Contacts
- Lixia Luo+8618665666679
- Danyue Chen+8615989073809
Related Studies
- Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence TomographyRecruiting · Oregon Health and Science University · Portland, Oregon
- Intraoperative OCT Guidance of Intraocular Surgery IIRecruiting · Duke University · Durham, North Carolina
- Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital PopulationPHASE4 · Recruiting · University of California, San Francisco · San Francisco, California
- Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood CataractPHASE4 · Recruiting · EyePoint Pharmaceuticals, Inc. · Huntington Beach, California